Chongqing Taiji Industry (Group) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Taiji Industry (Group) with three other
companies in this sector in CHINA :
Joincare Pharmaceutical Group Industry Company Limited
sales of 11.98 billion Chinese Renmimbi [US$1.68 billion]
of which 99%
was Industry and Commerce),
Harbin Pharmaceutical Group Company Limited
(11.82 billion Chinese Renmimbi [US$1.66 billion]
of which 70%
was Medicine Trade), and
Shanghai Shyndec Pharmaceutical Co Ltd
(12.20 billion Chinese Renmimbi [US$1.71 billion]
of which 64%
was Drug Products).
During the year ended December of 2019, sales at
Chongqing Taiji Industry (Group) were 11.64 billion Chinese Renmimbi (US$1.63 billion).
increase of 8.9%
versus 2018, when the company's sales were 10.69 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chongqing Taiji Industry (Group)
(and since 2014, sales have increased a total of 68%).
Sales of Service saw an increase
15.3% in 2019, from
50.63 million Chinese Renmimbi to 58.37 million Chinese Renmimbi.